ArticleFrontiers in oncology2024
An efficient deep learning strategy for accurate and automated detection of breast tumors in ultrasound image datasets.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A synergistic framework integrating global context and structural features for breast ultrasound lesion detection.Frontiers in oncology · 2026Article
- A hybrid attention network for accurate breast tumor segmentation in ultrasound images.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer ranks as one of the leading malignant tumors among women worldwide in terms of incidence and mortality. Ultrasound examination is a critical method for breast cancer screening and diagnosis in China. However, conventional breast ultrasound examinations are time-consuming and labor-intensive, necessitating the development of automated and efficient detection models. Methods: We developed a novel approach based on an improved deep learning model for the intelligent auxiliary diagnosis of breast tumors. Combining an optimized U2NET-Lite model with the efficient DeepCardinal-50 model, this method demonstrates superior accuracy and efficiency in the precise segmentation and classification of breast ultrasound images compared to traditional deep learning models such as ResNet and AlexNet. Results: Our proposed model demonstrated exceptional performance in experimental test sets. For segmentation, the U2NET-Lite model processed breast cancer images with an accuracy of 0.9702, a recall of 0.7961, and an IoU of 0.7063. In classification, the DeepCardinal-50 model excelled, achieving higher accuracy and AUC values compared to other models. Specifically, ResNet-50 achieved accuracies of 0.78 for benign, 0.67 for malignant, and 0.73 for normal cases, while DeepCardinal-50 achieved 0.76, 0.63, and 0.90 respectively. These results highlight our model's superior capability in breast tumor identification and classification. Conclusion: The automatic detection of benign and malignant breast tumors using deep learning can rapidly and accurately identify breast tumor types at an early stage, which is crucial for the early diagnosis and treatment of malignant breast tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.